# Pilocarpine

## Salagen 5mg

| TAH Drug Code      | [OSALA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OSALA)                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head & neck. Treatment of symptoms of dry mouth in patients with Sjogren's syndrome.                                                           |
| Dosing             | Head & neck cancer - Radiation-induced xerostomia: Initially 5 mg TID. Usual dosage range: 15-30 mg daily (do not exceed 10 mg/dose). Sjogren's syndrome - Xerostomia: 5 mg QID.                                                                            |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                               |
| Contraindications  | Conditions in which miosis is undesirable (eg, acute iritis, narrow-angle glaucoma). Hypersensitivity to pilocarpine hydrochloride or any component of the product. Pupillary block glaucoma (ophthalmic solution). Uncontrolled asthma (oral formulation). |
| Adverse Effects    | Sweating, nausea, diarrhea, chills, flushing, urinary frequency, dizziness, asthenia, headache, dyspepsia, lacrimation, edema, abdominal pain, amblyopia, vomiting, pharyngitis, hypertension.                                                              |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Moderate Risk                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/pilocarpine-drug-information)                                                                                                                                                                                  |

